HER2 Testing in Breast Cancer – 2023 Guideline Update
This evidence-based guideline update addresses uncommon clinical scenarios and improved clarity for infrequent HER2 test results of uncertain biologic or clinical significance
This evidence-based guideline update addresses uncommon clinical scenarios and improved clarity for infrequent HER2 test results of uncertain biologic or clinical significance
Abstract. Oncogenesis and progression of pancreatic ductal adenocarcinoma (PDAC) is driven by complex interactions between the neoplastic component and the tumor microenvironment (TME), which includes…
Information about the artificial intelligence and bioinformatics workshop for the Early Detection Research Network, August 2024
Lawmakers aren’t willing to meet the president’s budget requests, casting doubt on reaching the program’s ambitious goal.
Lawmakers aren’t willing to meet the president’s budget requests, casting doubt on reaching the program’s ambitious goal.
Read and download our press releases.
Lawmakers aren’t willing to meet the president’s budget requests, casting doubt on reaching the program’s ambitious goal.
Cell Death Discovery – Circadian rhythm regulates the function of immune cells and participates in the development of tumors
Please note that this special conference will take place as an in-person event in Boston and will not live-stream content for virtual participation. The conference…
Accumulated evidence highlights that exercise can modulate multiple cytokines, influencing transcriptional pathways, and reprogramming certain metabolic processes, ultimately promoting antitumor immunity and enhancing the efficacy…
Pancreatic ductal adenocarcinoma (PDAC) is an extremely lethal cancer that accounts for over 90% of all pancreatic cancer cases. With a 5-year survival rate of…